Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Which stocks will surge next?
Unlock AI-picked Stocks
Zepp Health Corp (ZEPP)
Add to/Remove from a Portfolio
Add to Watchlist
0.8849
+0.0449
+5.35%
After Hours
0.8530
-0.0319
-3.6049%
0:00:00 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 50,571
- Bid/Ask: 0.8400 / 0.9500
- Day's Range: 0.8400 - 0.9000
Zepp Health
0.8849
+0.0449
+5.35%
- Discussions
- Recent Sentiments
- User Rankings
ZEPP User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Zepp Health Corp share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Donald wang | 1 | 1 | 1 | 100 | +25.2% |
| 2 | Ruan Camargo | 2 | 2 | 1 | 50 | +16.11% |
| 3 | Asier Sua | 4 | 4 | 3 | 75 | +13.97% |
| 4 | Mariano Del Valle | 1 | 1 | 1 | 100 | +13.59% |
| 5 | David Santiago | 1 | 1 | 1 | 100 | +11.81% |
| 6 | Stef Speliers | 1 | 0 | 0 | 0 | +11.66% |
| 7 | riccardo bellemo | 1 | 0 | 0 | 0 | +10.59% |
| 8 | Tiziana Russo | 1 | 1 | 1 | 100 | +10.38% |
| 9 | Sander Chen | 1 | 1 | 1 | 100 | +9.44% |
| 10 | Hermann Albrecht | 1 | 1 | 1 | 100 | +7.8% |
| 11 | Андрей Горелик | 1 | 0 | 0 | 0 | +7.51% |
| 12 | alvaro lopez cordero | 1 | 0 | 0 | 0 | +6.92% |
| 13 | Miguel | 1 | 1 | 1 | 100 | +6.31% |
| 14 | Dmitry Tovpeko | 1 | 1 | 1 | 100 | +6.1% |
| 15 | Nieves Ooooooo | 1 | 1 | 1 | 100 | +5.24% |
| 16 | Chen Mo | 1 | 1 | 1 | 100 | +4.16% |
| 17 | Ying Zhang | 1 | 1 | 1 | 100 | +4.09% |
| 18 | andrea fatelli | 1 | 1 | 1 | 100 | +3.08% |
| 19 | Mon Zin | 1 | 0 | 0 | 0 | +2.57% |
| 20 | José dvdc | 2 | 2 | 1 | 50 | +1.49% |
| 21 | Андрей Горелик | 1 | 1 | 1 | 100 | +0.96% |
| 22 | Boris Shamuilov | 1 | 1 | 1 | 100 | +0.37% |
| 23 | Dean Burton | 1 | 0 | 0 | 0 | +0.35% |
| 24 | Andras Lorincz | 1 | 1 | 0 | 0 | 0% |
| 25 | Brian Li | 2 | 2 | 1 | 50 | -0.28% |
| 26 | dario fanelli | 1 | 1 | 0 | 0 | -0.82% |
| 27 | Pedro Duarte | 1 | 0 | 0 | 0 | -1.86% |
| 28 | Jean Puentz | 2 | 2 | 1 | 50 | -2.01% |
| 29 | Лев Самоловских | 1 | 1 | 0 | 0 | -2.98% |
| 30 | 르르 부 | 1 | 1 | 0 | 0 | -3.38% |
| 31 | Santi M Moriel | 1 | 1 | 0 | 0 | -4.38% |
| 32 | Дмитрий Васько | 1 | 1 | 0 | 0 | -4.66% |
| 33 | dario fanelli | 1 | 1 | 0 | 0 | -6.13% |
| 34 | Boch Saints | 1 | 1 | 0 | 0 | -7% |
| 35 | Thomas Heps | 1 | 1 | 0 | 0 | -7.88% |
| 36 | David Santiago | 1 | 1 | 0 | 0 | -7.96% |
| 37 | Javier Alpízar Chacón | 1 | 1 | 0 | 0 | -8.06% |
| 38 | Carlos Campero | 1 | 1 | 0 | 0 | -9.97% |
| 39 | Yusuf Huang | 1 | 1 | 0 | 0 | -11.04% |
| 40 | Ash Sa | 1 | 1 | 0 | 0 | -12.04% |
| 41 | Nicolas Pou | 1 | 1 | 0 | 0 | -12.84% |
| 42 | Miki Oliva Serrano | 1 | 1 | 0 | 0 | -17.9% |
| 43 | Leandro Larrosa | 1 | 1 | 0 | 0 | -18.11% |
| 44 | Stefano Bacchiocchi | 1 | 1 | 0 | 0 | -20.83% |
| 45 | Omar Díez Pérez | 1 | 1 | 0 | 0 | -27.24% |
| 46 | Ondřej Kála | 4 | 3 | 1 | 33.33 | -29.74% |
| 47 | Andras Lorincz | 1 | 1 | 0 | 0 | -32.19% |
| 48 | Eliseu Bittencourt Júnior | 1 | 1 | 0 | 0 | -100% |
| 49 | Yoh Oohashi | 1 | 1 | 0 | 0 | -100% |
| 50 | Luke Geng | 1 | 1 | 0 | 0 | -100% |
Write your thoughts about Zepp Health Corp
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review